SetPoint Medical | LinkedIn (original) (raw)

Medical Equipment Manufacturing

Valencia, California 6,929 followers

Regulating Inflammation - through the nervous system

Discover all 75 employees

About us

SetPoint Medical is a privately held clinical-stage healthcare company dedicated to treating patients with autoimmune diseases. The company is developing a novel platform designed to stimulate the vagus nerve to activate innate anti-inflammatory pathways to produce a systemic immune-restorative effect. SetPoint Medical’s platform technology is designed to offer patients and providers a treatment alternative for rheumatoid arthritis, inflammatory bowel disease, and other chronic autoimmune conditions with potentially less risk and cost than drug therapy.

Industry

Medical Equipment Manufacturing

Company size

51-200 employees

Headquarters

Valencia, California

Type

Privately Held

Specialties

Inflammatory diseases, Neuromodulation, autoimmune disease, rheumatoid arthritis, and vagus nerve stimulation

Locations

Employees at SetPoint Medical

Updates

6,929 followers
3h Edited
We're excited to announce late-breaking data from the RESET-RA study at the American College of Rheumatology’s #ACR24. New positive data through 24 weeks of follow-up support SetPoint System's potential as a first-of-its-kind neuroimmune modulation treatment for adults living with rheumatoid arthritis (RA). “The results from the RESET-RA study, highlighting improvements in disease severity and joint protection, underpin the continued positive clinical impact of neuroimmune modulation as a potential novel treatment for rheumatoid arthritis,” said John Tesser, MD, FACP, FACR, MACR of Arizona Arthritis & Rheumatology Associates, PC in Phoenix, AZ, and national rheumatologist principal investigator of the study. Learn more about the late-breaking data in today's press release: https://lnkd.in/eHeAMRkk #TheSetPointAdvantage #RheumatoidArthritis #RAThis communication contains information about a device not yet approved in the United States for commercial use. The Setpoint System is limited by United States law to investigational use only.
SetPoint Medical Announces Late-Breaking Data from RESET-RA Study at ACR Convergence 2024 https://setpointmedical.com
Excited to support Arthritis Foundation’s disease awareness and patient advocacy efforts again this year!

National Senior Director, California Coast Classic Bike Tour at Arthritis Foundation
1mo
Day 8 and $2910 raised thanks to Jeff Lo and family. 💚 Our awesome partners at SetPoint Medical welcomed us to Carpinteria yesterday with fanfare at their pop up banana stand! 🍌🚴🏻🎉 Help me reach my goal as we roll into Malibu on our final leg today: https://lnkd.in/gdE2b3CY Arthritis Foundation
SetPoint Medical reposted this
🎉 Join us at the Congress of Clinical Rheumatology West 2024 in San Diego from September 26th to 29th! 🌟 Don't miss Dr. David N. Chernoff's groundbreaking talk on Neuroimmune Modulation for the Treatment of Rheumatoid Arthritis. This is a unique opportunity to learn about the latest advancements in RA treatment from an esteemed expert in the field. 📅 Mark your calendars and register now to elevate your practice with cutting-edge insights, network with peers, and earn CME credits. 📍 Hilton San Diego Bayfront 🔗 Register Here: https://lnkd.in/eGjnh_hh #CCRWest #Rheumatology #MedicalConference #SanDiego
6,929 followers
8mo Edited
In the spirit of #MSAwarenessWeek, we are thrilled to announce that SetPoint’s neuroimmune modulation platform has received Breakthrough Device Designation from the FDA for the treatment of multiple sclerosis (MS). This designation from the FDA recognizes the potential of our therapeutic approach to meet a critical and unmet medical need: promoting remyelination in individuals living with relapsing-remitting multiple sclerosis (RRMS), which no currently approved treatment achieves. “This significant milestone highlights the platform potential of Setpoint’s device and therapeutic approach for the treatment of multiple chronic conditions,” said Murthy Simhambhatla, Chief Executive Officer of Setpoint Medical. “As next steps, we look forward to working collaboratively with the FDA to initiate the first-of-its-kind clinical trial to investigate our device for people living with RRMS.”#TheSetPointAdvantageLearn more about this important milestone and its implications for MS treatment in the full press release:
SetPoint Medical Receives FDA Breakthrough Device Designation for its Neuroimmune Modulation Platform for the Treatment of Multiple Sclerosis https://setpointmedical.com

Join now to see what you are missing

Join now

SetPoint Medical | LinkedIn (original) (raw)

Medical Equipment Manufacturing

Valencia, California 6,929 followers

Regulating Inflammation - through the nervous system

About us

Locations

Employees at SetPoint Medical

Updates

Join now to see what you are missing

Similar pages

Browse jobs

Funding